Ginkgo Bioworks Says GPT-5 Beat State-of-the-Art in Protein Synthesis by 40%
Ginkgo Bioworks' autonomous lab, connected to OpenAI's GPT-5, reportedly surpassed existing benchmarks in cell-free protein synthesis by 40% — a striking result at the intersection of AI and wet-lab biology.
Ginkgo Bioworks announced that its autonomous laboratory system, integrated with OpenAI's GPT-5, beat the state-of-the-art in cell-free protein synthesis (CFPS) by 40%. As @Ginkgo reported, the system operates with a significant degree of autonomy — GPT-5 is not just analyzing data but actively directing experimental design and iteration in the lab.
Unlock the full briefing
Get every story in today's briefing, the full archive, and the daily AI intelligence brief.
All stories today
Full archive
Daily brief
Cancel anytime. Payments powered by Stripe.